Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD.

Front Pharmacol · 2022 · PMC9554617 · PMID 36249771

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

They found merely a decreasing trend throughout the whole study period in FIB and hsCRP.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.